Drug intelligence / Profile preview

Xiao'er Biantong Granule

Development stage
Phase 1
Lead developer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Xiao'er Biantong Granule (also known as Xiao'er Tongbian Granule) is a traditional Chinese medicine (TCM) granule developed for the treatment of pediatric functional constipation, particularly for cases with traditional Chinese medicine dyspepsia syndrome (food accumulation syndrome). Formulated from a clinical experience prescription of Dr. Chen Yonghui, the herbal mixture contains active ingredients such as Atractylodes macrocephala (白术), Aurantii Fructus (枳壳), Magnoliae Officinalis Cortex (厚朴), and Raphani Semen (莱菔子) to invigorate the spleen, regulate qi, and promote digestion and defecation. Originally developed as Xiao'er Biantong Granule, it was approved by the National Medical Products Administration (NMPA) of China in August 2026 under the name Xiao'er Tongbian Granule as a Class 1.1 TCM innovative drug.

Other names
XEBT granulesXiao'er Biantong GranulesXiao'er Tongbian GranuleXiao'er Tongbian Granules小儿便通颗粒小儿通便颗粒
02

Targets

AQP3 (Aquaporin-3 channel protein)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Xiao'er Biantong Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao'er Biantong Granule.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call